drugset / Trial / NCT02432885

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

NCT02432885

RandomizedParallel-groupOpen-labelTreatment

Summary

This trial intends to evaluate myocardial Fibrosis progression in Duchenne and Becker Muscular Dystrophy, as well the influence of ACE inhibitors in fibrosis progression. Additionally, this study aims to determine genetic predictors of cardiac involvement in these dystrophies.

Timeline

Start
2009-06
Primary completion
2012-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Enalapril Other / unclassified 20 mg